ACTRN12609000005257已完成4 期
Clinical trial with ivermectine 150 mcg/kg for microfilarial clearance and observation of side-effects in the treatment of infections with Mansonella ozzardi
niversity of Sao Paulo0 个研究点目标入组 80 人开始时间: 2009年1月6日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 5 Years 至 60 Years（—）
- 性别
- All
入选标准
- •1-)Mansonella ozzardi parasitaemia present on hemoscopy
- •2-)Older than 4 years and younger than 61 years
- •3-)Not pregnant or breast-feeding
- •4-) Volunteer
排除标准
- •1-)Pregnant or breast-feeding women
- •2-)Less than 5 years old and older than 60 years
研究者
相似试验
招募中
4 期
A trial of community wide treatment to reduce scabies in a village setting in northern IndiaSkin - Dermatological conditionsInfection - Other infectious diseasesScabiesACTRN12619001712190The Nossal Institute for Global Health (University of Melbourne)2,200
进行中（未招募）
1 期
Study of the efficacy of ivermectin in the treatment and prevention of COVID-19EUCTR2020-001994-66-ESFundació Assistencial Mútua Terrassa266
已完成
3 期
Clinical Endpoint Study of Ivermectin 0.5% LotionHead LiceNCT03301649Actavis Inc.905
尚未招募
不适用
â??To study the effectiveness of Ivermectin with standard of care treatmentversus standard of care treatment for COVID 19 cases. A Pilot StudyCTRI/2020/04/024858Max Super Speciality Hospital A Unit of Devki Devi Foundation
尚未招募
2 期
Study to assess efficacy of Ivermectin as prophylaxis of COVID -19CTRI/2020/05/025333R D Gardi Medical College